4925 HABA LABORATORIES, INC. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

4925

TSE Standard

HABA LABORATORIES, INC.

1,554

JPY

-41

(-2.57%)

Dec 23, 3:30 pm JST

9.92

USD

Dec 23, 1:30 am EST

Result

PTS

outside of trading hours

ー

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2021	14,307	226	250	216	57.2	40	May 11, 2021	J-GAAP
Mar, 2022	12,908	-316	-292	-269	-71.1	40	May 11, 2022	J-GAAP
Mar, 2023	12,038	-609	-582	-707	-187.2	40	May 11, 2023	J-GAAP
Mar, 2024	12,324	-187	-191	-2,118	-560.3	40	May 10, 2024	J-GAAP
Mar, 2025 Guidance	12,650	410	400	400	105.8	40	May 10, 2024	J-GAAP
YoY	+2.6%	－	－	－	－

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2020	May 10, 2019	20,100	3,180	3,170	2,160	40	J-GAAP
	Mar 23, 2020	18,400	1,890	1,870	1,040	40	J-GAAP
Results	May 11, 2020	18,369	1,997	1,975	1,313	40	J-GAAP
Mar, 2021	May 11, 2020	Available in future release
	Feb 12, 2021
Results	May 11, 2021
Mar, 2022	May 11, 2021
	Feb 10, 2022
Results	May 11, 2022
Mar, 2023	May 11, 2022
	Feb 10, 2023
Results	May 11, 2023
Mar, 2024	May 11, 2023
	Feb 9, 2024
Results	May 10, 2024
Mar, 2025	May 10, 2024	12,650	410	400	400	40	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2000	4,828	+49.7	Available in future release
Mar, 2001	6,627	+37.3
Mar, 2002	7,303	+10.2
Mar, 2003	8,115	+11.1
Mar, 2004	9,841	+21.3
Mar, 2005	10,081	+2.4
Mar, 2006	10,777	+6.9
Mar, 2007	11,028	+2.3
Mar, 2008	11,042	+0.1
Mar, 2009	11,182	+1.3
Mar, 2010	11,318	+1.2
Mar, 2011	11,809	+4.3
Mar, 2012	13,578	+15.0
Mar, 2013	13,233	-2.5
Mar, 2014	13,786	+4.2
Mar, 2015	13,181	-4.4
Mar, 2016	14,811	+12.4
Mar, 2017	16,135	+8.9
Mar, 2018	17,885	+10.8
Mar, 2019	19,253	+7.6
Mar, 2020	18,369	-4.6
Mar, 2021	14,307	-22.1
Mar, 2022	12,908	-9.8
Mar, 2023	12,038	-6.7
Mar, 2024	12,324	+2.4
Mar, 2025 Guidance	12,650	+2.6	410	－	400	－	105.8	－

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2023	12,038	-609	-5.1	-6.31	-4.66	0.79	-187.2
Mar, 2024	12,324	-187	-1.5	-21.97	-15.64	0.91	-560.3
Mar, 2025 Guidance	12,650	410	3.24	4.80	3.24	1.02	105.8

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	19,253	3,095	3,100	2,088	1,519.2
Fiscal Year	Mar, 2019	Mar, 2019	Mar, 2019	Mar, 2019	Mar, 2002

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2021	6,924	252	276	195	51.6	40	May 11, 2022	J-GAAP
Oct - Mar, 2022	6,386	-263	-258	-477	-126.3	40	May 11, 2023	J-GAAP
Oct - Mar, 2023	6,797	277	272	-1,773	-469.0	40	May 10, 2024	J-GAAP
Oct - Mar, 2024 Guidance	7,195	446	422	415	109.8	40	Nov 13, 2024	J-GAAP
YoY	+5.9%	+61.0%	+55.1%	－	－

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2022	-316	1,498	1,714	-216	-1,512	5,651	36.03	J-GAAP
Mar, 2023	-609	-159	55	-214	-676	4,817	32.87	J-GAAP
Mar, 2024	-187	-1,028	-587	-441	171	3,959	31.85	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2022	5,652	-346	-324	-230	-61.0	ー	Nov 11, 2022	J-GAAP
Apr - Sep, 2023	5,527	-464	-463	-345	-91.3	ー	Nov 10, 2023	J-GAAP
Apr - Sep, 2024	5,455	-36	-22	-15	-4.1	ー	Nov 13, 2024	J-GAAP
YoY	-1.3%	+92.2%	+95.2%	+95.7%	+95.5%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2022	3,083	-421	-418	-580	-153.5	-13.7	Feb 10, 2023	J-GAAP
Jan - Mar, 2023	3,303	158	160	103	27.3	4.8	May 11, 2023	J-GAAP
Apr - Jun, 2023	2,569	-290	-288	-215	-56.9	-11.3	Aug 10, 2023	J-GAAP
Jul - Sep, 2023	2,958	-174	-175	-130	-34.4	-5.9	Nov 10, 2023	J-GAAP
Oct - Dec, 2023	3,109	-109	-110	-567	-149.9	-3.5	Feb 9, 2024	J-GAAP
Jan - Mar, 2024	3,688	386	382	-1,206	-319.0	10.5	May 10, 2024	J-GAAP
Apr - Jun, 2024	2,670	-37	-29	-22	-5.9	-1.4	Aug 13, 2024	J-GAAP
Jul - Sep, 2024	2,785	1	7	7	1.9	0.0	Nov 13, 2024	J-GAAP
YoY	-5.8%	－	－	－	－

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Oct - Dec, 2019	4,552	-11.2	Available in future release
Jan - Mar, 2020	4,285	-18.6
Apr - Jun, 2020	3,223	-28.4
Jul - Sep, 2020	3,430	-31.8
Oct - Dec, 2020	3,679	-19.2
Jan - Mar, 2021	3,975	-7.2
Apr - Jun, 2021	3,028	-6.1
Jul - Sep, 2021	2,956	-13.8
Oct - Dec, 2021	3,574	-2.9
Jan - Mar, 2022	3,350	-15.7
Apr - Jun, 2022	2,787	-8.0
Jul - Sep, 2022	2,865	-3.1
Oct - Dec, 2022	3,083	-13.7
Jan - Mar, 2023	3,303	-1.4
Apr - Jun, 2023	2,569	-7.8
Jul - Sep, 2023	2,958	+3.2
Oct - Dec, 2023	3,109	+0.8
Jan - Mar, 2024	3,688	+11.7
Apr - Jun, 2024	2,670	+3.9
Jul - Sep, 2024	2,785	-5.8	1	－	7	－	1.9	－

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	5,262	1,260	1,259	875	222.5
Fiscal Year	Mar, 2019	Mar, 2019	Mar, 2019	Mar, 2019	Mar, 2019

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2022	3,077.51	74.2	15,685	11,637	11,257	0.22	May 11, 2022	J-GAAP
Mar, 2023	2,849.03	73.5	14,655	10,773	10,398	0.19	May 11, 2023	J-GAAP
Mar, 2024	2,249.65	68.4	12,431	8,507	8,128	0.28	May 10, 2024	J-GAAP
Apr - Sep, 2024	ー	67.5	12,360	8,339	7,961	0.27	Nov 13, 2024	J-GAAP

HABA LABORATORIES, INC.(4925) Financial Results